工银瑞信中证创新药产业ETF(516060)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
-13,131,582.33 |
-22,723,798.78 |
-12,463,655.42 |
-11,058,497.29 |
| 本期利润 |
12,250,252.03 |
-22,530,366.17 |
-37,802,809.66 |
-16,562,212.04 |
| 加权平均基金份额本期利润 |
0.06 |
-0.08 |
-0.15 |
-0.08 |
| 本期加权平均净值利润率(%) |
11.27 |
-17.50 |
-30.69 |
-13.34 |
| 本期基金份额净值增长率(%) |
13.83 |
-15.58 |
-25.76 |
-11.44 |
| 期末可供分配利润 |
-77,502,781.09 |
-156,060,671.76 |
-155,944,297.33 |
-108,412,248.74 |
| 期末可供分配基金份额利润 |
-0.46 |
-0.52 |
-0.58 |
-0.43 |
| 期末基金资产净值 |
92,734,618.91 |
143,176,728.24 |
113,293,102.67 |
141,825,151.26 |
| 期末基金份额净值 |
0.54 |
0.48 |
0.42 |
0.57 |
| 基金份额累计净值增长率(%) |
-45.53 |
-52.15 |
-57.92 |
-43.32 |
微信公众号
证券之星APP
基本资料
